
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| gL(L) | 865 | 65.9% | -0.93 | 454 | 72.1% |
| CA(L) | 176 | 13.4% | -4.14 | 10 | 1.6% |
| CentralBrain-unspecified | 79 | 6.0% | -0.58 | 53 | 8.4% |
| CRE(L) | 58 | 4.4% | -0.16 | 52 | 8.3% |
| b'L(L) | 58 | 4.4% | -1.47 | 21 | 3.3% |
| PED(L) | 27 | 2.1% | -0.43 | 20 | 3.2% |
| SCL(L) | 30 | 2.3% | -4.91 | 1 | 0.2% |
| SIP(L) | 11 | 0.8% | 0.24 | 13 | 2.1% |
| RUB(L) | 3 | 0.2% | -0.58 | 2 | 0.3% |
| LAL(L) | 1 | 0.1% | 1.58 | 3 | 0.5% |
| SLP(L) | 4 | 0.3% | -inf | 0 | 0.0% |
| bL(L) | 1 | 0.1% | 0.00 | 1 | 0.2% |
| upstream partner | # | NT | conns KCg-s2 | % In | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 91 | DA | 350 | 28.0% | 0.6 |
| KCg-m (L) | 193 | DA | 279 | 22.4% | 0.7 |
| VP3+_vPN (L) | 1 | GABA | 55 | 4.4% | 0.0 |
| PAM08 (L) | 14 | DA | 54 | 4.3% | 0.8 |
| KCg-s3 (L) | 1 | DA | 52 | 4.2% | 0.0 |
| PPL103 (R) | 1 | DA | 43 | 3.4% | 0.0 |
| KCg-s4 (L) | 1 | DA | 37 | 3.0% | 0.0 |
| KCg-s1 (L) | 1 | DA | 34 | 2.7% | 0.0 |
| KCg (L) | 1 | DA | 27 | 2.2% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 27 | 2.2% | 0.0 |
| SLP184 (L) | 1 | ACh | 23 | 1.8% | 0.0 |
| VP1m+VP2_lvPN2 (L) | 3 | ACh | 22 | 1.8% | 0.6 |
| PPL103 (L) | 1 | DA | 21 | 1.7% | 0.0 |
| APL (L) | 1 | GABA | 18 | 1.4% | 0.0 |
| M_lPNm13 (L) | 3 | ACh | 18 | 1.4% | 0.5 |
| PAM08 (R) | 8 | DA | 13 | 1.0% | 0.6 |
| DPM (L) | 1 | DA | 11 | 0.9% | 0.0 |
| PAM07 (L) | 4 | DA | 11 | 0.9% | 0.7 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 9 | 0.7% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 8 | 0.6% | 0.0 |
| KCa'b'-ap1 (L) | 8 | DA | 8 | 0.6% | 0.0 |
| PAM05 (L) | 4 | DA | 7 | 0.6% | 0.2 |
| PAM05 (R) | 4 | DA | 6 | 0.5% | 0.6 |
| VP1m+_lvPN (L) | 2 | Glu | 6 | 0.5% | 0.0 |
| PPL101 (L) | 1 | DA | 5 | 0.4% | 0.0 |
| PAM01 (L) | 2 | DA | 5 | 0.4% | 0.6 |
| PAM12 (L) | 4 | DA | 5 | 0.4% | 0.3 |
| KCa'b'-m (L) | 4 | DA | 5 | 0.4% | 0.3 |
| M_lvPNm48 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| PPL101 (R) | 1 | DA | 4 | 0.3% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 4 | 0.3% | 0.0 |
| M_lPNm11A (L) | 2 | ACh | 4 | 0.3% | 0.5 |
| aMe23 (L) | 1 | Glu | 3 | 0.2% | 0.0 |
| M_adPNm5 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 3 | 0.2% | 0.0 |
| MBON33 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| M_l2PNm16 (L) | 2 | ACh | 3 | 0.2% | 0.3 |
| FR1 (R) | 2 | ACh | 3 | 0.2% | 0.3 |
| KCa'b'-ap2 (L) | 3 | DA | 3 | 0.2% | 0.0 |
| SMP709m (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| SMP142 (L) | 1 | unc | 2 | 0.2% | 0.0 |
| PPL104 (R) | 1 | DA | 2 | 0.2% | 0.0 |
| VP1m+VP2_lvPN1 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| MB-C1 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| MBON12 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| MBON05 (R) | 1 | Glu | 2 | 0.2% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| FC2B (R) | 2 | ACh | 2 | 0.2% | 0.0 |
| PAM12 (R) | 2 | DA | 2 | 0.2% | 0.0 |
| PAM06 (R) | 2 | DA | 2 | 0.2% | 0.0 |
| PAM01 (R) | 2 | DA | 2 | 0.2% | 0.0 |
| PFR_a (R) | 2 | unc | 2 | 0.2% | 0.0 |
| MBON09 (L) | 2 | GABA | 2 | 0.2% | 0.0 |
| LAL141 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON01 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PPL104 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| FR2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PAM15 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| SMP007 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD2a4_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP204 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE072 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| KCab-s (L) | 1 | DA | 1 | 0.1% | 0.0 |
| FC2A (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP006 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PAM07 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| CRE080_d (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LC33 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP385 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| EL (R) | 1 | OA | 1 | 0.1% | 0.0 |
| PPL105 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PPL202 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| PPL102 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| SLP457 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LAL156_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| V_ilPN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns KCg-s2 | % Out | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 90 | DA | 389 | 19.0% | 0.6 |
| KCg-m (L) | 191 | DA | 311 | 15.2% | 0.8 |
| MBON05 (R) | 1 | Glu | 152 | 7.4% | 0.0 |
| PAM08 (L) | 22 | DA | 149 | 7.3% | 1.3 |
| APL (L) | 1 | GABA | 87 | 4.3% | 0.0 |
| MBON09 (L) | 2 | GABA | 85 | 4.2% | 0.0 |
| KCg-s3 (L) | 1 | DA | 62 | 3.0% | 0.0 |
| KCg (L) | 1 | DA | 52 | 2.5% | 0.0 |
| PAM08 (R) | 15 | DA | 43 | 2.1% | 0.6 |
| PAM07 (L) | 7 | DA | 38 | 1.9% | 0.5 |
| MBON32 (L) | 1 | GABA | 34 | 1.7% | 0.0 |
| MBON01 (L) | 1 | Glu | 31 | 1.5% | 0.0 |
| KCg-s1 (L) | 1 | DA | 31 | 1.5% | 0.0 |
| MBON04 (R) | 1 | Glu | 30 | 1.5% | 0.0 |
| KCg-s4 (L) | 1 | DA | 29 | 1.4% | 0.0 |
| MBON11 (L) | 1 | GABA | 29 | 1.4% | 0.0 |
| MBON33 (L) | 1 | ACh | 26 | 1.3% | 0.0 |
| PPL103 (R) | 1 | DA | 25 | 1.2% | 0.0 |
| MBON21 (L) | 1 | ACh | 25 | 1.2% | 0.0 |
| MBON26 (L) | 1 | ACh | 24 | 1.2% | 0.0 |
| DPM (L) | 1 | DA | 23 | 1.1% | 0.0 |
| MBON35 (L) | 1 | ACh | 22 | 1.1% | 0.0 |
| PPL101 (L) | 1 | DA | 20 | 1.0% | 0.0 |
| PAM01 (L) | 9 | DA | 19 | 0.9% | 1.3 |
| CRE048 (L) | 1 | Glu | 16 | 0.8% | 0.0 |
| PPL103 (L) | 1 | DA | 14 | 0.7% | 0.0 |
| PAM12 (L) | 8 | DA | 14 | 0.7% | 0.6 |
| MBON29 (L) | 1 | ACh | 12 | 0.6% | 0.0 |
| KCa'b'-ap1 (L) | 9 | DA | 11 | 0.5% | 0.3 |
| MBON12 (L) | 2 | ACh | 10 | 0.5% | 0.8 |
| MBON27 (L) | 1 | ACh | 9 | 0.4% | 0.0 |
| MBON05 (L) | 1 | Glu | 8 | 0.4% | 0.0 |
| PPL101 (R) | 1 | DA | 8 | 0.4% | 0.0 |
| PAM07 (R) | 6 | DA | 8 | 0.4% | 0.6 |
| MBON04 (L) | 1 | Glu | 7 | 0.3% | 0.0 |
| PPL202 (L) | 1 | DA | 7 | 0.3% | 0.0 |
| MBON22 (L) | 1 | ACh | 7 | 0.3% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 7 | 0.3% | 0.0 |
| PAM01 (R) | 7 | DA | 7 | 0.3% | 0.0 |
| LAL159 (L) | 1 | ACh | 5 | 0.2% | 0.0 |
| PAM05 (L) | 3 | DA | 5 | 0.2% | 0.6 |
| PAM12 (R) | 4 | DA | 5 | 0.2% | 0.3 |
| PPL104 (R) | 1 | DA | 4 | 0.2% | 0.0 |
| PPL102 (R) | 1 | DA | 4 | 0.2% | 0.0 |
| FR1 (R) | 3 | ACh | 4 | 0.2% | 0.4 |
| EL (R) | 4 | OA | 4 | 0.2% | 0.0 |
| PAM06 (L) | 4 | DA | 4 | 0.2% | 0.0 |
| SMP376 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| PAM02 (R) | 1 | DA | 3 | 0.1% | 0.0 |
| CRE080_d (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| MB-C1 (L) | 1 | GABA | 3 | 0.1% | 0.0 |
| LAL002 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| LAL100 (L) | 1 | GABA | 3 | 0.1% | 0.0 |
| V_ilPN (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| MBON20 (L) | 1 | GABA | 3 | 0.1% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| PAM02 (L) | 2 | DA | 3 | 0.1% | 0.3 |
| CRE200m (R) | 2 | Glu | 3 | 0.1% | 0.3 |
| CRE022 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| CRE080_c (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MBON30 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| OA-VPM3 (L) | 1 | OA | 2 | 0.1% | 0.0 |
| PAM15 (L) | 1 | DA | 2 | 0.1% | 0.0 |
| FB4E_b (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| CRE067 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| CL129 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| CRE068 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| CRE051 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| FB4C (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| LAL100 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 2 | 0.1% | 0.0 |
| M_l2PNl20 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| PAM04 (L) | 2 | DA | 2 | 0.1% | 0.0 |
| FB4K (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| CB0951 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| SMP075 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| ATL036 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| FC2A (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| FB4K (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MBON29 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE012 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| SMP156 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP709m (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MBON03 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| LHPV9b1 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| LHPD5d1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| PPL104 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| CRE049 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE024 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LAL043_d (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| SMP114 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| PAM05 (R) | 1 | DA | 1 | 0.0% | 0.0 |
| CB1197 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| PAM15 (R) | 1 | DA | 1 | 0.0% | 0.0 |
| CRE079 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| SIP037 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE060 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP569 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SIP053 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CB3874 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP377 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LAL022 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SIP042_b (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE003_b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LAL071 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| FB5B (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| KCa'b'-m (L) | 1 | DA | 1 | 0.0% | 0.0 |
| FB4O (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE057 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| CB2018 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| mALB1 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| PAM10 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| FB2D (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE080_a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| M_lPNm11C (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE009 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| FB4R (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| EPG (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MBON24 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CL123_a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LHAV6g1 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| FB5I (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| LHAV3m1 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| SMP744 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| FB1G (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SIP087 (L) | 1 | unc | 1 | 0.0% | 0.0 |
| ExR6 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MBON22 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE107 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LAL156_a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE075 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.0% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 0.0% | 0.0 |
| MBON01 (R) | 1 | Glu | 1 | 0.0% | 0.0 |